Controlled Arterial Protection to Ultimately Remove Embolic Material - Trial NCT06103591
Access comprehensive clinical trial information for NCT06103591 through Pure Global AI's free database. This phase not specified trial is sponsored by EmStop Inc and is currently Not yet recruiting. The study focuses on Aortic Valve Stenosis. Target enrollment is 15 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
EmStop Inc
Timeline & Enrollment
N/A
Dec 01, 2023
Mar 01, 2024
Primary Outcome
Device procedural success
Summary
The objective of this study is to demonstrate device feasibility, safety and investigate
 performance of the EmStop Embolic Protection System when used as indicated in 15 subjects at
 2 investigational sites in the U.S.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06103591
Device Trial